Literature DB >> 34272270

Effects of Dopamine D1-Like Receptor Ligands on Food-Cocaine Choice in Socially Housed Male Cynomolgus Monkeys.

Paul W Czoty1, Michael A Nader2.   

Abstract

Although dopamine plays a prominent role in mediating cocaine's abuse-related effects, the specific roles of dopamine receptor subtypes are not fully understood. Whereas the effects of drugs acting at dopamine D2-like receptors (D2Rs) have been characterized, less is known about dopamine D1-like receptors (D1Rs). The present experiments examined the effects of drugs with varying intrinsic efficacy at D1R on the relative reinforcing strength of cocaine in male cynomolgus monkeys. Use of socially housed monkeys permitted the assessment of whether social status influenced the behavioral effects of D1R-acting drugs. The high-efficacy D1R agonist SKF 81297, low-efficacy D1R agonist SKF 38393, and D1R antagonist SCH 23390 were administered acutely to monkeys self-administering cocaine under a food-cocaine choice procedure in which a cocaine-choice dose-effect curve was determined daily. To assess selectivity of behavioral effects on cocaine choice, effects of doses that did not disrupt responding (indicated by a ≥35% decrease in total reinforcers delivered) were analyzed. Neither SKF 81297 nor SCH 23390 affected cocaine choice in dominant or subordinate monkeys. However, the low-efficacy agonist SKF 38393 selectively decreased cocaine choice; this effect was larger and only reached statistical significance in subordinate monkeys. Increasing the time between D1-acting drug administration and the cocaine choice session did not affect these results. The results indicate that, like D2R-acting drugs, the behavioral effects of D1R-acting drugs on cocaine choice can vary according to intrinsic efficacy and social status. Moreover, they demonstrate that D1R-acting drugs affect behavior under a narrower range of conditions than D2R-acting drugs. SIGNIFICANCE STATEMENT: Cocaine use disorder represents an insidious public health concern with no Food and Drug Administration-approved medications. Although dopamine receptors have been strongly implicated in mediating the abuse-related effects of cocaine, the roles of dopamine receptor subtypes are incompletely understood. The present study in nonhuman primates found that cocaine choice was decreased only by a low-efficacy D1R agonist, and that this effect depended on the social status of the monkey.
Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34272270      PMCID: PMC8626634          DOI: 10.1124/jpet.121.000701

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.402


  37 in total

1.  Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration.

Authors:  Drake Morgan; Kathleen A Grant; H Donald Gage; Robert H Mach; Jay R Kaplan; Osric Prioleau; Susan H Nader; Nancy Buchheimer; Richard L Ehrenkaufer; Michael A Nader
Journal:  Nat Neurosci       Date:  2002-02       Impact factor: 24.884

2.  Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys.

Authors:  Nicole H Mutschler; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2002-02-12       Impact factor: 4.530

3.  Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys.

Authors:  D M Platt; J K Rowlett; R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2001-09       Impact factor: 4.530

4.  The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats.

Authors:  D W Self; L Stein
Journal:  Brain Res       Date:  1992-06-12       Impact factor: 3.252

5.  Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.

Authors:  J Bergman; R D Spealman; B K Madras; S Rosenzweig-Lipson
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

6.  Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys.

Authors:  R Ranaldi; Z Wang; W L Woolverton
Journal:  Drug Alcohol Depend       Date:  2001-10-01       Impact factor: 4.492

Review 7.  Neurocircuitry of addiction.

Authors:  George F Koob; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 8.  Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).

Authors:  Jack Bergman
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

9.  Social status, environment, and atherosclerosis in cynomolgus monkeys.

Authors:  J R Kaplan; S B Manuck; T B Clarkson; F M Lusso; D M Taub
Journal:  Arteriosclerosis       Date:  1982 Sep-Oct

10.  Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats.

Authors:  Morgane Thomsen; Anders Fink-Jensen; David P D Woldbye; Gitta Wörtwein; Thomas N Sager; Rene Holm; Lauren M Pepe; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2008-07-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.